Ofirmev, a Cadence Pharmaceuticals product, is the first form of intravenous acetaminophen in the U.S. Cadence Pharmaceuticals is expected to launch the product in the early part of this year, according to the news report.
Read the news report about Ofirmev.
Read other coverage about FDA approvals:
– FDA Approves Mindray Medical Anesthesia System
– House Hears Arguments Over FDA’s Medical Device Approval Process
